Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, January 26, 2010

FDA warning: Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.